75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)
Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
† Study has passed its completion date and status has not been verified in more than two years.